DOCSLIB.ORG

Main Panel A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Main Panel A MAIN PANEL A 1 Clinical Medicine 2 Public Health, Health Services and Primary Care 3 Allied Health Professions, Dentistry, Nursing and Pharmacy 4 Psychology, Psychiatry and Neuroscience 5 Biological Sciences 6 Agriculture, Food and Veterinary Sciences MAIN PANEL B 7 Earth Systems and Environmental Sciences 8 Chemistry 9 Physics 10 Mathematical Sciences 11 Computer Sciences and Informatics 12 Engineering MAIN PANEL C 13 Architecture, Built Environment and Planning 14 Geography and Environmental Studies 15 Archaeology 16 Economics and Econometrics 17 Business and Management Studies 18 Law 19 Politics and International Studies 20 Social Work and Social Policy 21 Sociology 22 Anthropology and Development Studies 23 Education 24 Sport and Exercise Sciences, Leisure and Tourism MAIN PANEL D 25 Area Studies 26 Modern Languages and Linguistics 27 English Language and Literature 28 History 29 Classics 30 Philosophy 31 Theology and Religious Studies 32 Art and Design: History, Practice and Theory 33 Music, Drama, Dance, Performing Arts, Film and Screen Studies 34 Communication, Cultural and Media Studies, Library and Information Management SECRETARIAT 1 * denotes interdisciplinary member on a main panel, and interdisciplinary adviser on a sub-panel MAIN PANEL A Chair Professor John Iredale University of Bristol Deputy Chair Professor Sir Nilesh Samani British Heart Foundation Members Professor Doreen Cantrell University of Dundee Professor Peter Clegg University of Liverpool Professor David Crossman Chief Scientist Scottish Government Professor Dame Anna Dominiczak* University of Glasgow Professor Paul Elliott Imperial College London Professor Garret FitzGerald University of Pennsylvania Professor Susan Gathercole University of Cambridge Dr Jack Gauldie McMaster University Professor Bernadette Hannigan Public Health England Professor Anthony Hickey RTI International Dr Dermot Kelleher University of British Columbia Mr Imran Khan Wellcome Trust Professor Hugh McKenna Ulster University Dr David Mela Independent Professor Peter Morris* University of Nottingham Professor Richard Oliver Curtin University Dr Malcolm Skingle GlaxoSmithKline Professor Moira Whyte University of Edinburgh Observers Dr Jef Grainger Biotechnology and Biological Sciences Research Council Dr Ian Viney Medical Research Council Sub-panel 1: Clinical Medicine Chair Professor Moira Whyte University of Edinburgh Deputy Chair Professor Ian Hall University of Nottingham Members Professor David Adams University of Birmingham Professor Metin Avkiran British Heart Foundation Professor Cyrus Cooper* University of Southampton Professor Helen Cross University College London Professor Chris Griffiths University of Manchester Professor Paul Morgan Cardiff University Professor Jane Norman University of Edinburgh Professor Munir Pirmohamed University of Liverpool Professor Brian Walker Newcastle University 2 * denotes interdisciplinary member on a main panel, and interdisciplinary adviser on a sub-panel Professor Hugh Watkins University of Oxford Professor Jonathan Weber Imperial College London Additional assessment phase members Professor Mark Caulfield Queen Mary, University of London Professor Diana Eccles University of Southampton Professor Fiona Gilbert University of Cambridge Professor Gerard Graham University of Glasgow Professor Mark Hull University of Leeds Professor David Jones Newcastle University Professor David Menon University of Cambridge Professor Paul Moss University of Birmingham Professor Stephen Renshaw University of Sheffield Professor Manuel Salto-Tellez Queen's University Belfast Professor Gavin Screaton University of Oxford Professor Aziz Sheikh University of Edinburgh Professor Frank Sullivan University of St Andrews Professor Maria Zambon Public Health England Sub-panel 2: Public Health, Health Services and Primary Care Chair Professor Paul Elliott Imperial College London Deputy Chair Professor Frank Kee* Queen's University Belfast Members Professor Harry Campbell University of Edinburgh Professor Marion Campbell University of Aberdeen Mr Simon Denegri The Academy of Medical Sciences Professor Trish Greenhalgh University of Oxford Professor Kate Hunt University of Stirling Professor Paul Little University of Southampton Professor Tim Peters University of Bristol Additional assessment phase members Professor Deborah Ashby Imperial College London Professor Tony Avery University of Nottingham Professor Douglas Easton University of Cambridge Professor Alan Silman University of Oxford Professor Paula Williamson University of Liverpool Professor Olivia Wu University of Glasgow 3 * denotes interdisciplinary member on a main panel, and interdisciplinary adviser on a sub-panel Sub-panel 3: Allied Health Professions, Dentistry, Nursing and Pharmacy Chair Professor Hugh McKenna Ulster University Deputy Chair Professor Yvonne Barnett* Anglia Ruskin University Members Professor Richard Aspinall Rivock Ltd Professor Dame Jessica Corner University of Nottingham Professor Priscilla Harries Brunel University London Professor Doreen McClurg Glasgow Caledonian University Professor Afzal Mohammed Aston University Professor Christopher Nester University of Salford Professor Angus Walls University of Edinburgh Professor David Whitaker Cardiff University Dr Julie Woodley University of the West of England, Bristol Additional assessment phase members Professor Zeeshan Ahmad De Montfort University Professor Aedin Cassidy Queen’s University Belfast Professor Mary Chambers Kingston University Professor Charlotte Clarke University of Edinburgh Dr Simon Hackett Tyne & Wear NHS Trust Professor Sue Higham University of Liverpool Professor Carmel Hughes Queen's University Belfast Professor Simon Jackson University of Plymouth Professor Sallie Lamb* University of Oxford Professor Jayne Lawrence University of Manchester Professor Simon Mackay University of Strathclyde Professor Jill Macleod Clarke University of Southampton Professor Lorna MacPherson University of Glasgow Professor Kader Parahoo* Ulster University Professor Nigel Pitts King's College London Professor Jo Rycroft-Malone Lancaster University Professor Julius Sim Keele University Professor Julie Taylor University of Birmingham Professor Des Tobin University College Dublin Sub-panel 4: Psychology, Psychiatry and Neuroscience Chair Professor Susan Gathercole University of Cambridge Deputy Chairs Professor Jeremy Hall Cardiff University Professor Catherine Abbott University of Edinburgh 4 * denotes interdisciplinary member on a main panel, and interdisciplinary adviser on a sub-panel Members Professor Roger Barker University of Cambridge Professor Richard Crisp* Durham University Professor James Deuchars University of Leeds Professor Brendan Gough Leeds Beckett University Professor Matthew Hotopf King’s College London Professor Jane Ireland University of Central Lancashire Mersey Care NHS Trust Professor Matthew Lambon-Ralph University of Manchester Professor Courtenay Norbury University College London Professor Shirley Reynolds University of Reading Additional assessment phase members Professor Andrew Blamire Newcastle University Professor Mike Burton University of York Professor Helen Cassaday University of Nottingham Professor Patrick Haggard University College London Professor Elizabeth Meins University of York Professor Daryl O'Connor University of Leeds Professor Kathleen Rastle Royal Holloway, University of London Professor Richard Wade-Martins University of Oxford Professor Allan Young King's College London Sub-panel 5: Biological Sciences Chair Professor Doreen Cantrell University of Dundee Deputy Chair Professor Julian Dow University of Glasgow Members Professor Leo Brady* University of Bristol Professor Susan Brain King’s College London Professor Francesca Buffa* University of Oxford Dr Natalie Carter Arthritis Research UK Professor Neil Gow* University of Aberdeen Professor Pat Heslop-Harrison* University of Leicester Professor David Hosken* University of Exeter Professor Tracy Hussell University of Manchester Additional assessment phase members Professor Judith Allen University of Manchester Professor Dorothy Bennett St George's, University of London Professor Philip Biggin University of Oxford Professor Dominique Bonnet The Francis Crick Institute Professor Paula Booth King’s College London Professor Tim Dafforn University of Birmingham Professor Kevin Fox Cardiff University Professor Mark Harris University of Leeds 5 * denotes interdisciplinary member on a main panel, and interdisciplinary adviser on a sub-panel Professor Ian Henderson University of Birmingham Professor Graeme Milligan University of Glasgow Professor Stefan Pryzborski Durham University Professor Sonia Rocha University of Liverpool Professor Gail Taylor University of Southampton, University of California Sub-panel 6: Agriculture, Food and Veterinary Science Chair Professor Peter Clegg University of Liverpool Deputy Chair Professor Chris Elliott Queen's University Belfast Members Professor Liz Baggs University of Edinburgh Professor Lynn Frewer* Newcastle University Professor Anne-Marie Minihane University of East Anglia Professor Massimo Palmarini University of Glasgow Dr Gina Pinchbeck University of Liverpool Professor Guy Poppy Food Standards Agency Mr Mike Roper Independent Professor Linda Wooldridge University of Bristol Additional assessment phase members Dr Bryan Charleston The Pirbright Institute Professor Michael Gooding Aberystwyth University Professor Richard Mellanby University of Edinburgh Professor Euan Phimister University of Aberdeen
Load more

Recommended publications
  • Perspectives on 'Communicating Evidence About Medicines'
    Perspectives on 'Communicating evidence about medicines' A report of a one-day workshop held by the Academy of Medical Sciences on 6 June 2016 Disclaimer This report does not represent a formal Academy of Medical Sciences position on how best to communicate evidence about medicines. Rather this document reflects the wide-ranging discussions that took place at the workshop. The report of this meeting will feed into the Academy’s workstream on ‘How can we all best use evidence to judge the potential benefits and harms of medicines?'.1 We hope that this report will also encourage wider discussion about communicating evidence about medicines. We would therefore welcome feedback on the report. For further information, please contact Dr Rachel Brown, Policy Officer at the Academy of Medical Sciences ([email protected], 020 3141 3223). We are most grateful to Professor Theresa Marteau FMedSci for Chairing this workshop and to Professor Sir David Spiegelhalter OBE FRS for his helpful contributions in the development of this workshop. We are also especially thankful to Dr Paul Robinson, Dr Jacintha Sivarajah, and Dr Catherine Harvey for their contributions to the workshop which were given at short notice, and to all other individuals who contributed to the event. All web references were accessed in June/July 2016. This work is © Academy of Medical Sciences and is licensed under Creative Commons Attribution 4.0 International. 1. Led by Professor Sir John Tooke FMedSci, the workstream also includes workshops on evaluating evidence in health, conflicts of interest, and communicating evidence about medicines in the media.
    [Show full text]
  • Promoting the Use of Complex Innovative Designs in Clinical Trials
    Meeting March 20, 2018 Page 1 1 2 U.S. FOOD AND DRUG ADMINISTRATION 3 CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) 4 CENTER FOR BIOLOGIC EVALUATION AND RESEARCH (CBER) 5 6 7 Public Meeting: 8 Promoting the Use of Complex Innovative Designs 9 in Clinical Trials 10 11 Tuesday, March 20, 2018 12 8:35 a.m. 13 14 FDA White Oak Campus 15 10903 New Hampshire Avenue 16 Silver Spring, Maryland 20903 17 18 19 20 Reported by: KeVon Congo, 21 Capital Reporting Company 22 www.CapitalReportingCompany.com 202-857-3376 Meeting March 20, 2018 Page 2 1 A P P E A R A N C E S 2 Deborah Ashby, PhD 3 Imperial College London 4 Julie Beitz, MD 5 Office of Drug Evaluation III, CDER, FDA 6 Robyn Bent 7 Office of Biostatistics, CDER, FDA 8 Scott Berry, PhD 9 Berry Consultants, LLC 10 Frank Bretz, PhD 11 Novartis 12 Aloka Chakravarty, PhD 13 Office of Biostatistics, CDER, FDA 14 Shein-Chung Chow, PhD 15 Office of Biostatistics, CDER, FDA 16 Ivan Chan, PhD 17 AbbVie Inc. 18 Scott Emerson, MD, PhD 19 University of Washington 20 Steven Goodman, MD, PhD 21 Stanford University School of Medicine 22 www.CapitalReportingCompany.com 202-857-3376 Meeting March 20, 2018 Page 3 1 A P P E A R A N C E S 2 Frank Harrell, Jr., PhD 3 Vanderbilt University School of Medicine 4 Telba Irony, PhD 5 Office of Biostatistics and Epidemiology, CBER, 6 FDA 7 Laura Lee Johnson, PhD 8 Office of Biostatistics, CDER, FDA 9 Stefanie Kraus 10 Office of Regulatory Counsel, CDER, FDA 11 Lisa LaVange, PhD 12 University of North Carolina at Chapel Hill 13 J.
    [Show full text]
  • Practical Help for Specifying the Target Difference in Sample Size Calculations for Rcts : the DELTA2 Five-Stage Study, Including a Workshop
    This is a repository copy of Practical help for specifying the target difference in sample size calculations for RCTs : the DELTA2 five-stage study, including a workshop. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/152823/ Version: Published Version Article: Cook, J.A., Julious, S.A., Sones, W. et al. (18 more authors) (2019) Practical help for specifying the target difference in sample size calculations for RCTs : the DELTA2 five-stage study, including a workshop. Health Technology Assessment, 23 (60). pp. 1-88. ISSN 1366-5278 https://doi.org/10.3310/hta23600 © Queen’s Printer and Controller of HMSO 2019. This work was produced by Cook et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version.
    [Show full text]
  • Tackling the Structural Drivers of HIV
    ISSUE 31 • SUMMER 2012 Tackling the structural drivers of HIV In this issue… New MSc degrees in Nutrition and Global Mental Health Introducing the TB Centre Olympics and trafficking: the myths and the evidence CONTENTS Message from our Director 2012 Honorary Fellowships 3 Life at the School has been busy, with another Congratulations to our generation of students graduating from the School MSc class of 2011 4 during the Masters Graduation Day on 10 March and the Research Degrees Graduation Ceremony Health in the aftermath of war 5 on 8 June. These events are an important rite of passage for our graduates, marking a new phase Pioneering Bluetongue research 6 in their careers which will bring new experiences, Uncovering the myths and challenges and opportunities that will test the evidence around Olympics tools and expertise our graduates have been and trafficking 7 taught at the School. STRIVE: Tackling the During the Masters Graduation Day, we were very pleased to award honorary structural drivers of HIV 8-9 fellowships to Professor Sir Brian Greenwood, who this year has been knighted and awarded the Canada Gairdner Prize for his contribution to medicine Dramatic drop in child deaths 10 and public health, Professor Dame Valerie Beral, Director of Oxford’s Cancer Launch of collaborative Epidemiology Unit and formerly at the School, John Godfrey, a long standing infection research institute 11 School Board and Council member and Dr Tedros Adhanom Ghebreyesus, alumnus and the Ethiopian Minister for Health, whose leadership in Introducing the TB centre 12-13 malaria research and public health policy is internationally recognised.
    [Show full text]
  • Imperial College London School of Public Health Department Application Silver Award
    Imperial College London School of Public Health Department Application Silver Award 1 Name of Imperial College institution Department School of Public Health Focus of STEMM department Date of 30th November 2018 application Award Level Silver Institution Date: November 2018 Level: Athena Silver SWAN award Contact for Sapna Halder application Steven Riley Must be based in the department Ioanna Tzoulaki Email [email protected] [email protected] [email protected] Telephone 0207 594 9611 Departmental http://www.imperial.ac.uk/school-public-health website Note – email from ECU confirming 1000 extra words permitted since we are a Medical School with Clinical and Non-Clinical Staff, received 27th September 2018 and attached to this application. Department application Silver SPH Word limit 12,000 12,973 Recommended word count 1.Letter of endorsement 500 473 2.Description of the department 500 205 3. Self-assessment process 1,000 982 4. Picture of the department 2,000 2020 5. Supporting and advancing women’s careers 6,500 8352 6. Case studies 1,000 888 7. Further information 500 53 TABLE OF ABBREVIATIONS Abbreviation Meaning AGE Ageing Epidemiology Research Unit AS Athena SWAN AY Academic Year DirSPH Director of School of Public Health DM(s) Departmental Managers DSM Deputy School Manager EBS Epidemiology and Biostatistics EW Elsie Widdowson FT Full-Time FoM Faculty of Medicine GDPR General Data Protection Regulation HDAML Health Data Analytics & Machine Learning HoD(s) Head of Department(s) HoE Head of Education HR Human Resource
    [Show full text]
  • Annual Conference 2019 10Am – 6Pm, Wednesday 8 May 2019 Royal College of Physicians, 11 St Andrews Place, London NW1 4LE
    Annual Conference 2019 10am – 6pm, Wednesday 8 May 2019 Royal College of Physicians, 11 St Andrews Place, London NW1 4LE PROGRAMME (Subject to change) 09:00 – 10:00 Registration 10:00 – 10:15 Welcome and Chief Executive’s introduction James Parry, Chief Executive, UKRIO 10:15 – 10:45 How far have we come, and what are the challenges facing us now? Professor Sir Bernard Silverman FRS FAcSS, Chair, UKRIO; former Home Office Chief Scientific Adviser 10:45-11:20 Building a healthy research culture Professor Leanne Hodson, Professor of Metabolic Physiology/BHF Senior Research Fellow in Basic Science, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford Dr Sion Parry, Postdoctoral Researcher, University of Oxford 11:20 – 11:40 Break 11:40 – 12:30 PARALLEL SESSION A: PARALLEL SESSION B: PARALLEL SESSION C: The next chapter in research Scientific ecosystems and In it together: managing cross- integrity: perspectives from research reproducibility institutional research the Concordat signatories misconduct investigations Jennifer Evans, Senior Research Professor Marcus Munafò, Rowena Lamb, Head of Research Manager, Higher Education Funding UK Reproducibility Network; Integrity, University College Council for Wales Professor of Biological Psychology, London Samuel Roseveare, Policy Manager, University of Bristol Dr Rhys Morgan, Head of Policy, Universities UK Integrity and Governance, University of Cambridge Dr Anne Taylor, Head of Grants Operations, Wellcome Trust MAIN CONFERENCE HALL LINACRE ROOM SLOANE ROOM (Lower Ground
    [Show full text]
  • 2017–18 Annual Fundraising Report
    We are celebrating your support. Annual Fundraising Report 2017–18 Contents 2–3 President’s welcome. 4–7 We are bringing people together. 8–13 We are unleashing potential. 14–25 We are solving global problems. 26–41 We are recognising your Architect’s render of the planned School of Public Health. generosity. Front cover: Benjamin Hilton, President’s Scholar (Physics). Annual Fundraising Report 2017–18 1 2 Annual Fundraising Report 2017–18 We are grateful for your support. On behalf of everyone at Imperial College London, thank you for your support. Your philanthropy enables us to excel in research and education for the benefit of society. The stories in this report highlight some of the many ways that your donations make a difference in the quality of our research, the education and lives of our students, and our ability to make important advances in addressing society’s most pressing problems. Our public health researchers are working to improve children’s health in one of London’s most deprived neighbourhoods, and in communities around the world (p16). Alumnus Marit Mohn’s transformative gift will create a state-of-the-art centre for children’s health and wellbeing at our White City Campus. Quinbrook Infrastructure Partners are the benefactors of Imperial’s Centre for Climate Finance and Investment, where specialists are working to steer the business community towards safer, cleaner investments (p18). Our talented students benefit from biggest challenges we face. You will and non-profit, healthcare and generous scholarship donations see how gifts large and small make government institutions across the and they, in turn, contribute to a difference, from transforming the globe, and to sharing the wonder society.
    [Show full text]
  • The Politics of Evidence: from Evidence- Based Policy to the Good Governance of Evidence
    Justin Parkhurst The politics of evidence: from evidence- based policy to the good governance of evidence Book (Published version) Original citation: Parkhurst, Justin (2017) The politics of evidence: from evidence-based policy to the good governance of evidence. Routledge Studies in Governance and Public Policy. Routledge, Abingdon, Oxon, UK. ISBN 9781138939400 Reuse of this item is permitted through licensing under the Creative Commons: © 2017 The Author CC BY-NC-ND This version available at: http://eprints.lse.ac.uk/68604/ Available in LSE Research Online: December 2016 LSE has developed LSE Research Online so that users may access research output of the School. Copyright © and Moral Rights for the papers on this site are retained by the individual authors and/or other copyright owners. You may freely distribute the URL (http://eprints.lse.ac.uk) of the LSE Research Online website. ‘This book is a marvellous interdisciplinary synthesis, grounded in case examples and at once critical and constructive. As such, it is both instructive for policy practitioners as well as moving the scholarship of the field forward.’ –Vivian Lin, Professor of Public Health, La Trobe University, Australia ‘This is essential reading for anybody working on the smarter use of evidence by government. It catalogues the many biases twisting how research is used by policymakers. It also addresses a vital challenge in our sector – a lack of legitimacy. As well as the academic rigour of this book, there are practical tips on what we can do about these problems, and lessons from across the globe showing where we get it wrong – and how we might get it right.’ – Jonathan Breckon, Head of the Alliance for Useful Evidence, UK ‘This important book goes well beyond standard analyses of evidence informed policy with detailed discussions of the politics of evidence and the political origins (and the cognitive psychology) of bias in the use of research evidence.
    [Show full text]
  • Standards for Data and Statistics in the Regulation of Medicines
    17th November 2020 Standards for Data and Statistics in the Regulation of Medicines Professor Deborah Ashby Director of the School of Public Health Imperial College London How is cancer treated? Surgery Radiotherapy Chemotherapy Hormone treatments Monoclonal antibodies…. How do we know they work and are safe? How do we know we can trust the evidence? • Ensure the safety and effectiveness of medicines • Respond to public health disasters • Prohibited the importation of unsafe or adulterated drugs • Ineffective because of enforcement challenges and domestic patent medicines • 1906 Pure Food and Drugs Act ° Prohibited interstate commerce of unsafe drugs ° Required proper labeling ° Identified official standards for drugs • The Food, Drug, and Cosmetic Act of 1938 ° Required proof of safety ° Authorized inspections ° Outlawed false claims • Calls for revisions of the drug laws • Thalidomide disaster • The Kefauver-Harris Amendments of 1962 ° Required proof of effectiveness ° Gave FDA control over investigations ° Gave FDA authority to regulate advertising of prescription drugs ° Established good manufacturing practices • Early labels decorative • Drug labels today ° Indications ° Dosage ° Possible interactions ° Other information • Standard drug testing and approval process ° Preclinical testing ° Clinical studies – Phase I, II, III ° Postmarketing surveillance • FDA adopts science of risk management ° Identification of risks ° Balance of risks and benefits • All drugs have risks A Brief History of Statistics in Drug Regulation • 1964
    [Show full text]
  • Review of the Year 2014-2015
    INSPIRING EXCELLENCE REVIEW OF THE YEAR 2014/15 British Academy Review of the year 2014/15 1 CONTENTS Our Mission: To inspire, recognise and support high achievement in the humanities and social sciences throughout the UK and internationally, and to champion their role and value. 02 INTRODUCTION 15 STRENGTHENING POLICYMAKING Providing independent contributions 04 THE YEAR IN NUMBERS to public policy development, enhancing the policymaking process. The following sections reflect the six strategic priorities set 17 ENGAGING WITH THE PUBLIC out in the Academy’s Strategic Stimulating public interest in and Framework 2013–2018: understanding of the humanities and social sciences, and contributing 06 CHAMPIONING THE HUMANITIES to public debate. aND SOCIAL SCIENCES 19 PROMOTING INTERNatiONALISM Taking a lead in representing the Promoting UK research in humanities and social sciences, international arenas, fostering a global promoting their interests and approach across UK research and vigorously upholding their value. providing leadership in developing 08 ADVANCING RESEARCH global research links and expertise. Providing distinctive and 22 ABOUT THE ACADEMY complementary funding opportunities for outstanding people and innovative research. 12 FOSTERING EXCELLENCE Strengthening, extending and diversifying ways of recognising and celebrating high achievement in the humanities and social sciences. British Academy Review of the year 2014/15 1 INTRODUCTION This Review of the Year presents a Exemplifying this are the first three series In its policy activities, the Academy has The second, with the Department for summary of highlights from the past of The British Academy Debates. These took carried out highly regarded work on the International Development, will create a year, showing how the British Academy public discussions of a selected theme – UK’s constitution and on the multiple new body of international research on ways Ageing, then Immigration, then Well-being issues surrounding Scottish devolution.
    [Show full text]
  • Alumni Event: Meeting Minds Global 12-17 April 2021
    ALUMNI E-NEWSLETTER CONTENT: FEBRUARY 2021 We trust you and your families have kept well over this unprecedented year for us all. Following Government advice, our St Giles’ Building was closed from 24th March 2020 and duly remained closed until late August. Staff and students had to quickly adapt to remote working during this period and remarkably Department life was able to continue, albeit remotely. A small number of staff and students returned to working in the building at the end of August with the majority still working from home. In preparation for the start of Michaelmas Term, a system was set up that allowed every member of the Department to come in for half the week. Unfortunately, further disruption came in November, with the partial lockdown, and again after the Christmas break. Hilary Term has been extremely quiet, with only a small number of staff and students working in the building. ALUMNI EVENT: MEETING MINDS GLOBAL 12-17 APRIL 2021 For 2021 the Alumni Office are creating the opportunity for alumni around the world to come together and experience an array of exciting and innovative talks, and connect with each other. Content will be streamed live across three time zones, from London (BST), Hong Kong (HKT) and New York (EDT) with speakers sharing their experiences and expertise across a diverse range of topics. The Department of Statistics will have a virtual ‘Booth’ at Meeting Minds Global which you can visit at any time throughout the week as well as specific events for you to join. Please see details below: ❖ Live event
    [Show full text]
  • AMSTATNEWS the Membership Magazine of the American Statistical Association •
    December 2019 • Issue #510 AMSTATNEWS The Membership Magazine of the American Statistical Association • http://magazine.amstat.org Success LOOKS LIKE WSDS 2019 ALSO: ASA-AAAS Mass Media Fellow Shares What She Learned (Bio)Statistics Bachelor’s Degrees Nearly Quintuple This Decade SSYMPOSIUMDSS ON DATA SCIENCE & STATISTICS SDSS is designed for data scientists, computer scientists, and statisticians who analyze and visualize complex data. Innovative sessions focus on the following tracks: PARTICIPATE Contributed Paper Abstract Submission: MACHINE December 4, 2019 – January 30, 2020 LEARNING E-Poster Abstract Submission: December 4, 2019 – March 10, 2020 DATA VISUALIZATION ATTEND Online Registration and Housing Open: January 15, 2020 SOFTWARE & Early Registration Deadline: April 7, 2020 DATA SCIENCE TECHNOLOGIES Housing Reservation Deadline: May 12, 2020 Regular Registration Deadline: June 6, 2020 Onsite Registration: June 3–6, 2020 PRACTICE AND APPLICATIONS Learn more at ww2.amstat.org/sdss. COMPUTATIONAL BEYOND BIG DATA: STATISTICS COLLABORATION IN SCIENCE, INDUSTRY, AND SOCIETY EDUCATION PITTSBURGH, PA • JUNE 36, 2020 ® AMSTATNEWS DECEMBER 2019 • ISSUE #510 Executive Director Ron Wasserstein: [email protected] Associate Executive Director and Director of Operations features Stephen Porzio: [email protected] 3 President’s Corner Director of Science Policy Steve Pierson: [email protected] 5 ASA Journals in Need of Editors Director of Strategic Initiatives and Outreach 5 Latest Issue of Significance Asks Many Questions Donna LaLonde: [email protected]
    [Show full text]